logo

For the Inventor, By the Inventor

Bedford, MA, United States of America

Ixcela, Inc.


USPTO Granted Patents = 14



Trademarks = 6

Forward Citations = 19

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Wayne R Matson (10 out of 39 patents)

silverMedal Samantha A Matson (6 out of 6 patents)

bronzeMedal Erika N Ebbel-Angle (5 out of 5 patents)

4.  Srikant Sarangi (5 out of 5 patents)

5.  Erika N Angle (3 out of 3 patents)

6.  Balmiki Ray (1 out of 1 patent)

7.  Liewei Wang (1 out of 8 patents)

8.  Joanna Biernacka (1 out of 1 patent)

9.  Mark Frye (1 out of 1 patent)

10.  Richard M Weinshilboum (1 out of 35 patents)

11.  Taisei Mushiroda (1 out of 2 patents)

12.  Michiaki Kubo (1 out of 3 patents)

13.  Rima Kaddurah-Daouk (1 out of 29 patents)

14.  Beena E Thomas (1 out of 1 patent)

15.  Swati Bhasin (1 out of 1 patent)


14 patents:

1. 11287420 - Detection and modification of gut microbial population (2022-03-29),
2. 11287419 - Detection and modification of gut microbial population (2022-03-29),
3. 11287418 - Detection and modification of gut microbial population (2022-03-29),
4. 11287417 - Detection and modification of gut microbial population (2022-03-29),
5. 11122997 - Modulating the aryl hydrocarbon receptor system to treat major depressive disorder (2021-09-21),
6. 11041847 - Detection and modification of gut microbial population (2021-06-22),
7. 10278958 - IPA as a protective agent (2019-05-07),
8. 10220066 - Treatment of virus-based diseases of the skin (2019-03-05),
9. 10213468 - Treatment of virus-based diseases of the skin (2019-02-26),
10. 10034908 - Treatment of virus-based diseases of the skin (2018-07-31),
11. 10024842 - Methods and devices for quantitating blood samples (2018-07-17),
12. 9744155 - IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk (2017-08-29),
13. 9636325 - Indole lactic acid or a mixture of indole lactic acid and indole-3-propionic acid for treatment of Huntington's disease (2017-05-02),
14. 9603837 - IPA as a therapeutic agent and a biomarker for disease risk for Huntington's disease (2017-03-28),
Company Overview
Ixcela, Inc. is a biotechnology company based in Bedford, MA, specializing in the development of innovative solutions for health and wellness. The company focuses on harnessing the power of the microbiome and metabolomics to create products that enhance metabolic health and overall well-being. Ixcela's research emphasizes personalized health insights, aiming to empower individuals with data-driven approaches to improve their lifestyle and dietary choices, ultimately contributing to better health outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Ixcela, Inc. USPTO Patent Assignee Logo
14 Patents

#44 in Bedford, MA

#1,362 in Massachusetts

#22,319 in US

#42,249 in the World

Bedford, MA (US)
Bedford, MA, United States of America

Ixcela, Inc.

Forward Citations = 19

15 inventors:

goldMedal Wayne R Matson (10 out of 39 patents)

silverMedal Samantha A Matson (6 out of 6 patents)

bronzeMedal Erika N Ebbel-Angle (5 out of 5 patents)

4.  Srikant Sarangi (5 out of 5 patents)

5.  Erika N Angle (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ixcela, Inc.. Retrieved from https://idiyas.com/company/ixcela

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…